Vaccines Europe

Tweet this page
<
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
>
Registration as it was on 16 May 2024
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

600,000€ - 699,999€

Financial year: Jan 2023 - Dec 2023

Lobbyists (Full time equivalent)

1.25 Fte (4)

Lobbyists with EP accreditation

0

High-level Commission meetings

26

Lobbying Costs over the years

  • Info

    Vaccines Europe   (VE)

    EU Transparency Register

    53073567234-18 First registered on 23 Nov 2011

    Goals / Remit

    Vaccines Europe mission is to drive a sustainable and resilient vaccines Environment in Europe, protecting people against infectious diseases at all stage of life.

    Main EU files targeted

    Any health or pharmaceutical policy stemming from the European Institutions such as industrial policy, European Semester, Horizon Europe Research Programme, HTA policy, IP policy, Pharmaceutical strategy, One Health Approach to tackle AMR, paediatrics legislation, (COVID-19) outbreak measures, pandemic preparedness. Vaccines Europe also follows Clinical Trials regulation, European’s Beating Cancer plan, HERA, EMA, ECDC and Serious Cross Border Threats to Health regulations

    Address

    Head Office
    EFPIA ASBL8, rue Mil Neuf Cents
    Luxembourg 2157
    LUXEMBOURG
    EU Office
    EFPIA ASBLRue du Trône 108
    Brussels 1050
    BELGIUM

    Website

  • People

    Total lobbyists declared

    4

    Employment timeLobbyists
    50%1
    25%3

    Lobbyists (Full time equivalent)

    1.25

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    0 accreditations were / are live (in bold) for the selected state of 27 Jul 2024

    Name Start date End Date
    Magdalena RODRIGUEZ DE AZERO 30 Jan 2019 01 Feb 2020
    Mr Andrija VISIC 08 Jun 2018 08 Jun 2019
    Magdalena RODRIGUEZ DE AZERO 09 Dec 2017 01 Dec 2018
    Mr Andrija VISIC 27 Jun 2017 08 Jun 2018
    Magdalena RODRIGUEZ DE AZERO 16 Nov 2016 11 Nov 2017
    Mr Andrija VISIC 20 May 2016 19 May 2017
    Mr VISIC Andrija 20 May 2016 21 May 2016
    Magdalena RODRIGUEZ DE AZERO 30 Sep 2015 17 Sep 2016
    Mr Karam Adel Ali 30 Sep 2015 28 Apr 2016
    Magdalena RODRIGUEZ DE AZERO 23 Mar 2013 22 Mar 2014
    Mr Karam Adel Ali 23 Mar 2013 22 Mar 2014
    Magdalena RODRIGUEZ DE AZERO 12 Mar 2012 08 Feb 2013

    Complementary Information

    In 2024, the Vaccines Europe team is constituted of 7 employees of which one person spends 50% of his time, and three persons spend 25% of their time in activities falling under the scope of the Transparency Register. In total, it represents 4 persons involved in activities with the European Parliament.

    The Vaccines Europe scope of activities is wider than activities falling under the scope of the Transparency register.

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Trade and business associations

  • Networking

    Affiliation

    Vaccines Europe operates as a specialised group within the European Federation of Pharmaceutical Industries and Associations – EFPIA-, which operates as the representative organisation of the pharmaceutical industry in Europe.

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jan 2023 - Dec 2023

    Lobbying costs for closed financial year

    600,000€ - 699,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    NameAmount
    sue saville media 0€ - 10,000€
    acumen public affairs sprl 200,000€ - 299,999€
    apothecom 0€ - 10,000€
    baker mckzenzie 25,000€ - 49,999€
    fipra international srl 50,000€ - 99,999€
    cra (charles river associates 100,000€ - 199,999€
    mckinsey global institute 25,000€ - 49,999€
    leith 10,000€ - 24,999€
    fourtold 10,000€ - 24,999€
    evidera 10,000€ - 24,999€
    suzanne suggs 0€ - 10,000€
    ixl editorial limited 0€ - 10,000€
    european files 0€ - 10,000€

    Intermediaries for current year

    Name
    ixl editorial ltd
    acumen public affairs sprl
    kearney
    baker mckenzie bv/srl
    evidera
    cra

    Closed year Costs

    600,000€ - 699,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    None declared

    Groups (European Parliament)

    N/A

    Communication activities

    Vaccines Europe communication activities include:
    - Publishing new evidence (reports, leaflets, infographics) on the policies mentioned above
    - Drafting blog posts to share opinions
    - Organising events including Vaccines Europe members and external stakeholders
    - Disseminating our key messages through media partnerships and social media

    Other activities

    None declared

  • Meetings

    Meetings

    26 meetings found. Download meetings

    The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

    1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

    • Date 06 Nov 2020 Location Brussels - virtual
      Subject Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 30 Sep 2020 Location Online
      Subject Call with pharmaceutical and medical device supply Chain on COVID-19
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Karolina Herbout-Borczak (Cabinet member)
      • Stella Kyriakides (Commissioner)
      • Giorgios Rossides (Cabinet member)
      Other Lobbyists
    • Date 29 Jun 2020 Location Online
      Subject Call with pharmaceutical and medical device industry associations on COVID-19
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      • Giorgios Rossides (Cabinet member)
      • Karolina Herbout-Borczak (Cabinet member)
      Other Lobbyists
    • Date 29 Jun 2020 Location Brussels
      Subject Videoconference with Pharmaceutical Industry Associations to discuss shortages of medicines and medical devices including diagnostic tests in the context of COVID-19 pandemic
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 29 May 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 15 May 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 08 May 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 08 May 2020 Location Videoconference
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 29 Apr 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 29 Apr 2020 Location Videconference
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 23 Apr 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 23 Apr 2020 Location Videconference
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 17 Apr 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 09 Apr 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 09 Apr 2020 Location Videoconference
      Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 03 Apr 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 03 Apr 2020 Location Videoconference
      Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 27 Mar 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 27 Mar 2020 Location Videoconference
      Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 20 Mar 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 20 Mar 2020 Location Videoconference
      Subject Video call with Pharmaceutical Industrial Associations, the European Medicines Agency and the European Centre for Disease Prevention and Control, to discuss Possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Thierry Breton
      Portfolio Internal Market
      Attending
      • Thierry Breton (Commissioner)
      Other Lobbyists
    • Date 13 Mar 2020 Location Brussels
      Subject Video call with Pharmaceutical Industrial Associations and the European Medicines Agency to discuss possible shortages of medicines and medical devices for the Covid-19 outbreak
      Cabinet Cabinet of Commissioner Stella Kyriakides
      Portfolio Health
      Attending
      • Stella Kyriakides (Commissioner)
      Other Lobbyists
    • Date 21 Feb 2019 Location Brussels
      Subject introductory meeting
      DG Health and Food Safety
      Attending
      • Anne Bucher (Director-General)
    • Date 23 May 2018 Location Brussels
      Subject Discussion on Vaccination communication
      DG Health and Food Safety
      Attending
      • Xavier Prats Monné (Director-General)
    • Date 19 Oct 2017 Location Brussels
      Subject Discussion on vaccination
      DG Health and Food Safety
      Attending
      • Xavier Prats Monné (Director-General)
    • Date 20 Jan 2016 Location Brussels
      Subject Health programme on vaccination
      DG Health and Food Safety
      Attending
      • Xavier Prats Monné (Director-General)
Download this datacard